---
title: "Are ARX, FULC, EFSI Obtaining Fair Deals for their Shareholders?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299071859.md"
description: "Halper Sadeh LLC is investigating Accelerant Holdings (ARX), Fulcrum Therapeutics (FULC), and Eagle Financial Services (EFSI) for potential securities law violations and breaches of fiduciary duty. The firm alleges that insiders may receive unfair benefits in transactions involving ARX's sale to Thoma Bravo, FULC's merger with Slate Medicines, and EFSI's sale to John Marshall Bancorp. Shareholders are encouraged to contact the firm to discuss their rights regarding these deals."
datetime: "2026-09-15T15:29:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299071859.md)
  - [en](https://longbridge.com/en/news/299071859.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299071859.md)
generator: "portal-rs"
---

# Are ARX, FULC, EFSI Obtaining Fair Deals for their Shareholders?

***Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.*** 

***The proposed transactions may contain terms that could limit superior competing offers.***

***Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.***

, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

**Accelerant Holdings (NYSE: ARX)'s** sale to Thoma Bravo for $20.25 per share in cash. **If you are an Accelerant shareholder,** **click here to learn more about your rights and options.**

**Fulcrum Therapeutics, Inc. (NASDAQ: FULC)'s** merger with Slate Medicines, Inc. Upon closing of the proposed transaction, Fulcrum shareholders are expected to own 5.0% of the combined company. **If you are a Fulcrum shareholder,** **click here to learn more about your rights and options.**

**Eagle Financial Services, Inc. (NASDAQ: EFSI)'s** sale to John Marshall Bancorp, Inc. for 2.0 shares of John Marshall common stock for each share of EFSI common stock. **If you are an Eagle shareholder, click here to learn more about your legal rights and options**.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

Daniel Sadeh, Esq.

Zachary Halper, Esq.

One World Trade Center

85th Floor

New York, NY 10007

(212) 763-0060

\[email protected\]

\[email protected\] 

https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

### Related Stocks

- [FULC.US](https://longbridge.com/en/quote/FULC.US.md)
- [ARX.US](https://longbridge.com/en/quote/ARX.US.md)
- [EFSI.US](https://longbridge.com/en/quote/EFSI.US.md)
- [JMSB.US](https://longbridge.com/en/quote/JMSB.US.md)

## Related News & Research

- [Accelerant Announces Expiration of Go-Shop Period; $4B+ Thoma Bravo Deal Still Expected to Close H1 2027](https://longbridge.com/en/news/299897448.md)
- [Are FULC, WEAV, BWIN Obtaining Fair Deals for their Shareholders?](https://longbridge.com/en/news/299473918.md)
- [BlackRock Inc. Acquires Shares of 8,824,259 Fulcrum Therapeutics, Inc. $FULC](https://longbridge.com/en/news/297749671.md)
- [John Marshall Bancorp agrees to buy Eagle Financial in all-stock deal valued at USD 253 million](https://longbridge.com/en/news/298319940.md)
- [FULC: Merger forms a well-funded migraine biotech with clinical milestones expected through 2029](https://longbridge.com/en/news/296111857.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**